Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: A nationwide study of Btk deficiency in Greece

Scandinavian Journal of Immunology

Volumn 54, Issue 3, 2001, Pages 321-327

  Speletas, M ^a,b   Kanariou, M ^c   Kanakoudi Tsakalidou, F ^d   Papadopoulou Alataki, E ^d   Arvanitidis, K ^a   Pardali, E ^b   Constantopoulos, A ^e   Kartalis, G ^a   Vihinen, M ^f,g   Sideras, P ^a,b   Ritis, K ^a,h  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b LUND UNIVERSITY   (Sweden)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f Institute of Medical Technology   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; COMPLEMENTARY DNA; GENOMIC DNA; PRIMER DNA; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASSAY; CHILD; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME DEFICIENCY; EXON; FEMALE; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE MUTATION; GENE STRUCTURE; GENETIC ASSOCIATION; GREECE; HETEROZYGOTE DETECTION; HUMAN; MALE; MISSENSE MUTATION; MOLECULAR GENETICS; NON ISOTROPIC RIBONUCLEASE CLEAVAGE ASSAY; NONSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELATIVE; RELIABILITY; SEQUENCE ANALYSIS; X LINKED AGAMMAGLOBULINEMIA;

EID: 0035720573     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2001.00967.x     Document Type: Article

References (44)

1. Molecular and celular aspects of X-linked agammaglobulinemia
2. Molecular basis for three X-linked immune disorders
3. The Bruton's tyrosine kinase gene is expressed throughout B-cell differentiation, from early B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages
4. X-linked agammaglobulinemia
5. X-linked agammaglobulinemia. A clinical and molecular analysis
6. Unusual patterns of exon skipping in Btuton tyrosine kinase are associated with mutations involving the intron 17 3 splice site
7. The gene involved in X-linked agammaglobulinemia (XLA) is a member of the src family of protein-tyrosine kinases
8. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
9. Nonreceptor tyrosine kinases
10. New impressions of Src and Hck
11. Expression of a novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 near kit
12. Itk, a T cell tyrosine kinase gene inducible by interleukin 2
13. Molecular cloning and analysis of the human Tec protein-tyrosine kinase
14. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITC/TEC/TXK family located in chromosome Xp22
15. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells
16. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK - Functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling
17. Function of Bruton's tyrosine kinase in mast and B cells
18. Bruton's tyrosine kinase deficiency in macrophages inhibits nitric oxide generation leading to enhancement of IL-12 induction
19. Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis
20. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: Localization of mutations associated with varied clinical presentations and course in X-chromosome-linked agammaglobulinemia
21. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia
22. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinemia (XLA)
23. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: A nationwide study of Btk deficiency in Japan
24. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinemia
25. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia
26. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia
27. Mutations in Btk in patients with presumed X-linked agammaglobulinemia
28. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course
29. Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia
30. Carrrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation
31. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia patients
32. X chromosome inactivation patterns in normal females
33. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
34. Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukemia
35. Structural basis for chromosome X-linked agammaglobulinemia: A tyrosine kinase disease
36. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia
37. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: Phosphotyrosine-binding and circular dichroism analysis
38. Discordant phenotype in siblings with X-linked agammaglobulinemia
39. Extreme variation in X-linked agammaglobulinemia phenotype in a three-generation family
40. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinemia (XLA): The use of protein analysis as a diagnostic indicator of XLA
41. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations
42. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes
43. Monogenic traits are not simple: Lessons from phenylketonuria
44. Phenotypes of patients with 'simple' mendelian disorders are complex traits. Thresholds, modifiers, systems dynamics